Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;60(1):24-31.
doi: 10.1007/s00535-024-02182-z. Epub 2024 Dec 9.

Standard technique in Japan for measuring hepatic venous pressure gradient

Affiliations
Review

Standard technique in Japan for measuring hepatic venous pressure gradient

Yusuke Imai et al. J Gastroenterol. 2025 Jan.

Abstract

Background: Direct measurement of portal venous pressure (PVP) is invasive, so the hepatic venous pressure gradient (HVPG) is commonly measured to evaluate portal hypertension (PH). HVPG is the gold standard for estimating PVP but few reports have covered standardized measurement techniques.

Methods: This study validated standardized techniques for PVP measurement.

Results: In Western countries, electronic transducers are commonly used to measure PVP, whereas the water column method is still frequently applied in Japan. Setting a reference point for accurate PVP measurement is important but complicated. According to Japanese guidelines, the reference point for PVP measurement is 10 cm above the dorsal surface or in the midaxillary line. For simpler determination, the anterior axillary point, defined as the point of convergence between the proximal pectoralis major muscle and arm when both arms are positioned against the trunk in a supine position, can be used as the reference point. New methods, such as endoscopic ultrasound-guided portal pressure gradient, offer less invasive alternatives. Non-invasive methods like elastography measure liver and spleen stiffness, which correlate with HVPG. The Baveno VII criteria incorporate measurements of liver and splenic stiffness for risk stratification. Biomarkers such as type IV collagen, M2BPGi, and FIB-4 score also predict HVPG. The Baveno VII consensus emphasizes the status of HVPG as the gold standard while advocating for non-invasive alternative methods to improve patient care and monitor treatment efficacy.

Conclusions: Continued development of non-invasive tests is crucial for safer, more convenient PH management.

Keywords: Baveno VII; Elastography; HVPG; PVP; WHVP.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Hepatic venous pressure gradient and portal hypertension. Relationships between HVPG, other noninvasive tests, and clinical manifestations. cACLD compensated advanced chronic liver disease, CSPH clinically significant portal hypertension, HVPG hepatic venous pressure gradient, LSM liver stiffness measurement, PH portal hypertension, SSM splenic stiffness measurement. Modified from the figures of De Franchis et al. [5], Suk [17], Garcia-Tsao et al. [6], and Albilllos et al. [7]
Fig. 2
Fig. 2
Hepatic venography image during HVPG measurement. a Homogeneous findings on sinusoidgram. b Inhomogeneous findings on sinusoidgram and irregular findings of the hepatic vein (arrow). c Hepatic venous anastomosis (arrowhead)
Fig. 3
Fig. 3
Anterior axillary point as a reference point for PVP measurement. Point A: Anterior axillary point is the convergence point between the proximal pectoralis major and the arm with both arms positioned against the trunk. The height of the anterior axillary point is approximately equal to the height of the midaxillary line (Line B) of the upper abdomen

Similar articles

References

    1. Myers JD, Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest. 1951;30:662–3.
    1. Lu Q, Leong S, Lee KA, et al. Hepatic venous- portal gradient (HVPG) measurement: pearls and pitfalls. Br J Radiol. 2021;94:20210061. - PMC - PubMed
    1. Tetangco EP, Silva RG, Lerma EV. Portal hypertension: etiology, evaluation, and management. Review Dis Mon. 2016;62:411–26. - PubMed
    1. Kulkarni AV, Rabiee A, Mohanty A. Management of portal hypertension. J Clin Exp Hepatol. 2022;12:1184–99. - PMC - PubMed
    1. De Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74. - PMC - PubMed

LinkOut - more resources